All Type of News
“Belviq has a high prescription rate, which was secured by its safety”“In fact, Belviq has been prescribed a lot. A bit pricey, but its safety seems to secure the amount of prescriptions.”
After liquidation of ‘sibutramine,’ a obesity treatment, ...
|
Pharmaceutical companies’ desire to have drug price reflecting value of new drugs
The academic world and industry have agreed that the pharmaceutical industry requires an environment which creates extension of expenses of domestic pharmaceutical companies for the global expansion of the pharmaceuti...
Hanmi Pharm wins the final ‘Viagra’ design trial reversing the second oneReversing its second trial, Hanmi Pharm won the ‘Viagra’ design lawsuit against Pfizer Korea.
On the 15th, the Supreme Court announced dismissal of the Pfizer’s claim, an injun...
|
Sudden resignation of President Choon-yup Lee at Takeda Pharmaceuticals KoreaIt was observed President Choon-yup Lee who launched Takeda Pharmaceuticals Korea has resigned the position in the fifth year of his service last 14th.
Born in 1959, President ...
|
“Unidentifiable, encrypted preparation information is not personal information” Kim & Jang argued
Sent from Ginus to IMS between October 2011 and December 2014, the number of patients’ medical prescription information was 720 million cases; sent from the Korea Pharmaceutical Information Center to IMS between Octob...
Result of pharmaceutical companies’ avoidance in children OTC drug market
“How has the Janssen’s pain reliever, ‘Tylenol,’ kept its position as a large blockbuster for a long time even with numerous controversy?”
“What is the reason why the children OTC drug market, particularly, has been ...
What are worst obstacles in generic product exportation?
“Due to different approval processes of each country, it is hard to handle smooth pharmaceutical exports to a new country.” “Since a number of exporting countries ask us to re-conduct equivalent tests and clinical tri...
A great number of Swedish pharmaceutical leaders visit Korea to discuss life science cooperation
Embassy of Switzerland in Korea will hold the 2nd Swiss-Korean Life Science Symposium in cooperation with the Korea Health Industry Development Institute from the 22nd(Thursday) to 23rd(Friday) of October at JW ...
Will Gilead take over the hepatitis C market, too?
Gilead has attracted attention of the industry if it would continue the success of its domestic antivirus treatment even in the hepatitis C treatment market.
Recently, Gilead has actively established a hepatitis C pr...
Only accepted when companies accept weighted average?
At the 2015 9th Drug Price Deliberation Committee, a lot of treatments crossed the health insurance threshold. However, most of them had higher chances to be non-benefited only with cost effectiveness, but pharmaceuti...
